schizandrin has been researched along with Cirrhosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Park, JH; Yoon, J | 1 |
1 other study(ies) available for schizandrin and Cirrhosis
Article | Year |
---|---|
Schizandrin inhibits fibrosis and epithelial-mesenchymal transition in transforming growth factor-β1-stimulated AML12 cells.
Topics: Animals; Cell Line; Cyclooctanes; Epithelial-Mesenchymal Transition; Fibrosis; Lignans; Liver Diseases; Mice; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Polycyclic Compounds; RNA, Small Interfering; Smad2 Protein; Smad3 Protein; Smad4 Protein; Transforming Growth Factor beta1 | 2015 |